Bruce A. J. Ponder
Molecular Biology · 2000–2013
A researcher in the Science corpus: 16 papers; trusts 9 researchers and is trusted by 12 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 138 citations into it; #2,814 of 17,773 by trust here, #1,821 by citations
- Oncology — 21 citations into it
- Pathology and Forensic Medicine — 8 citations into it
Whom Bruce A. J. Ponder trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Bruce A. J. Ponder overall
- Ryuji Hamamoto
- Yusuke Nakamura
- N. Dohmae
- Takehiro Suzuki
- Makoto Nakakido
- G. Toyokawa
- Lianhua Piao
- Hyun-soo Cho
- S. Hayami
- Zhenzhong Deng
Papers from Bruce A. J. Ponder's perspective
Ordered by how strongly the researchers Bruce A. J. Ponder trusts endorse each paper. Same corpus, a different order for every researcher.
- Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins (Nature)
- Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain (Nature)
- Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. (Cell)
- Genome-wide map of nucleosome acetylation and methylation in yeast. (Cell)
- The language of covalent histone modifications (Nature)
- Regulation of chromatin structure by site-specific histone H3 methyltransferases (Nature)
- SET Domain-containing Protein, G9a, Is a Novel Lysine-preferring Mammalian Histone Methyltransferase with Hyperactivity and Specific Selectivity to Lysines 9 and 27 of Histone H3* (Journal of Biological Chemistry)
- SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
- MLL translocations, histone modifications and leukaemia stem-cell development (Nature Reviews. Cancer)
- Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. (Molecules and Cells)
Their papers
- Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers (2011) — 455 citations
- Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway (2010) — 222 citations
- Abstract 3019: Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells (2011) — 207 citations
- Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer (2011) — 114 citations
- Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. (2011) — 120 citations
- Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression. (2012) — 179 citations
- Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B (2012) — 120 citations
- Mutations truncating the EP300 acetylase in human cancers (2000) — 625 citations
- RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation. (2012) — 196 citations
- Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway. (2011) — 100 citations
- The Histone Demethylase JMJD2B Plays an Essential Role in Human Carcinogenesis through Positive Regulation of Cyclin-Dependent Kinase 6 (2011) — 68 citations
- The genetics and genomics of cancer (2003) — 623 citations
- A common coding variant in CASP8 is associated with breast cancer risk (2007) — 597 citations
- The histone methyltransferase Wolf–Hirschhorn syndrome candidate 1‐like 1 (WHSC1L1) is involved in human carcinogenesis (2013) — 67 citations
- The JmjC domain‐containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene (2012) — 96 citations
- Polygenic susceptibility to breast cancer and implications for prevention (2002) — 854 citations